Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

FDA Talent Hunt: Better To Recruit From Academia Than Industry?

This article was originally published in The Tan Sheet

Executive Summary

CDER Oncology office head Richard Pazdur says making FDA more academic could help with retention. In addition to fewer staff than needed to complete its work, FDA’s hiring problem makes it more difficult for the agency to stay abreast of new scientific discoveries and technology.

Advertisement

Related Content

FDA Reorganization Advocates Seek Senate Boost For Disease-Oriented Structure
Califf Supports Combo Products Pathway At Confirmation Hearing
FDA Personnel Growth Looks To Have Plateaued For Drugs Program
Show Me The Money: FDA Recruitment Efforts Challenged By Government Salaries
FDA Generics Director’s Departure Shows Why Chemistry Matters
CDER Taps Genzyme Exec As Deputy Director For Science Operations
Spielberg’s Replacement At FDA Also Will Have Strong Industry Ties
Oncology Drug Applications Migrate As Part Of FDA's Reorganization Of OOP

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register